Tools · Private company
Orca Biosystems, Inc.
Track this companyFree. Adds Orca Biosystems, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials87 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Orca-TPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Standard-of-CarePhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Orca-TPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- OrcaGraft (Orca-Q)Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Orca-THematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple MyelomaPHASE1 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07759102 · fetched Nov 12, 2026
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePHASE2 · RECRUITING · started Dec 9, 2025ClinicalTrials.gov NCT07216443 · fetched Nov 12, 2026
- Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)PHASE1_PHASE2 · RECRUITING · started Aug 16, 2022ClinicalTrials.gov NCT05322850 · fetched Nov 12, 2026
- Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 21, 2022ClinicalTrials.gov NCT05316701 · fetched Nov 12, 2026
- Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted GraftPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 7, 2021ClinicalTrials.gov NCT05088356 · fetched Nov 12, 2026
- Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 21, 2019ClinicalTrials.gov NCT04013685 · fetched Nov 12, 2026
- A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesPHASE1 · RECRUITING · started Apr 8, 2019ClinicalTrials.gov NCT03802695 · fetched Nov 12, 2026
- Orca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesAVAILABLEClinicalTrials.gov NCT07346105 · fetched Nov 12, 2026